Fortrans Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Diarrhoea is an expected effect resulting from the use of FORTRANS. Nausea and vomiting have been reported at the start of administration, usually disappearing with continued administration.
The following table lists adverse reactions collected from clinical trial data, and adverse events reported from post-marketing sources. The frequency of adverse reactions are as follows: Very common (≥1/10), Common (≥1/100 to <1/10), Uncommon (≥1/1000 to <1/100), Rare (≥1/10000 to <1/1000), Very rare (<1/10000), Unknown frequency (cannot be estimated from the available data). (See table.)

Click on icon to see table/diagram/image

Reporting of suspected adverse reactions: Reporting of suspected adverse reactions after a marketing authorization has been granted to the drug is important. It allows continuous surveillance of the medicine's benefit/risk ratio. Health professionals can report any suspected adverse reaction.

View ADR Reporting Link

Fortrans Adverse Reactions

Manufacturer:

Mayoly

Distributor:

DCH Auriga - Healthcare